These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
8. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice. Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749 [TBL] [Abstract][Full Text] [Related]
9. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773 [TBL] [Abstract][Full Text] [Related]
10. GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. Hermida MA; Dinesh Kumar J; Leslie NR Adv Biol Regul; 2017 Aug; 65():5-15. PubMed ID: 28712664 [TBL] [Abstract][Full Text] [Related]
11. Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin. Malhowski AJ; Hira H; Bashiruddin S; Warburton R; Goto J; Robert B; Kwiatkowski DJ; Finlay GA Hum Mol Genet; 2011 Apr; 20(7):1290-305. PubMed ID: 21212099 [TBL] [Abstract][Full Text] [Related]
12. Altered glucose homeostasis in mice with liver-specific deletion of Src homology phosphatase 2. Matsuo K; Delibegovic M; Matsuo I; Nagata N; Liu S; Bettaieb A; Xi Y; Araki K; Yang W; Kahn BB; Neel BG; Haj FG J Biol Chem; 2010 Dec; 285(51):39750-8. PubMed ID: 20841350 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice. Shum M; Bellmann K; St-Pierre P; Marette A Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling. Gao S; Duan C; Gao G; Wang X; Yang H Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876 [TBL] [Abstract][Full Text] [Related]
15. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Shah OJ; Wang Z; Hunter T Curr Biol; 2004 Sep; 14(18):1650-6. PubMed ID: 15380067 [TBL] [Abstract][Full Text] [Related]
16. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. Tremblay F; Marette A J Biol Chem; 2001 Oct; 276(41):38052-60. PubMed ID: 11498541 [TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
18. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1). Ge Y; Yoon MS; Chen J J Biol Chem; 2011 Oct; 286(41):35675-35682. PubMed ID: 21852229 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. Moore SF; Hunter RW; Hers I J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393 [TBL] [Abstract][Full Text] [Related]
20. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. Kang S; Chemaly ER; Hajjar RJ; Lebeche D J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]